CalciMedica News and Activities
Executives
View the org chart displaying its 16 main executives
Most searched biographies at CalciMedica
- Rachel Leheny, Director and Chief Executive Officer
- Robert Wilson, Chairman of the Board
- Evgeny Zaytsev, Director
Popular executive movements at CalciMedica
- Fred Middleton, Director, has left the company (posted on July 8 2026).
- Evgeny Zaytsev has joined the company as Director (posted on July 8 2026).
- Fred Guerard, Director, has left the company (posted on July 8 2026).
Create your alert
to follow the executive moves at CalciMedica.
Biotechnology
CalciMedica has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).
Popular M&A news in Biotechnology
- Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
- The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
- MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
Popular contacts in Biotechnology
News
Press releases by CalciMedica
- CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data | CalciMedica, Inc.
- CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates | CalciMedica, Inc.
- CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program | CalciMedica, Inc.
- CalciMedica Reports 2025 Financial Results and Provides Clinical Updates | CalciMedica, Inc.
- CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation | CalciMedica, Inc.
- CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates | CalciMedica, Inc.
- CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension | CalciMedica, Inc.
- CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 | CalciMedica, Inc.
- CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ | CalciMedica, Inc.
- CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference | CalciMedica, Inc.
- View more press releases Close
Social media about CalciMedica
- CalciMedica on Wikipedia, Google News & Yahoo Finance
- CalciMedica on LinkedIn, X (Twitter) & YouTube
